BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26339383)

  • 1. Comparison of structural genetics of non-schistosoma-associated squamous cell carcinoma of the urinary bladder.
    Molitor M; Junker K; Eltze E; Toma M; Denzinger S; Siegert S; Knuechel R; Gaisa NT
    Int J Clin Exp Pathol; 2015; 8(7):8143-58. PubMed ID: 26339383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA copy number changes in Schistosoma-associated and non-Schistosoma-associated bladder cancer.
    El-Rifai W; Kamel D; Larramendy ML; Shoman S; Gad Y; Baithun S; El-Awady M; Eissa S; Khaled H; Soloneski S; Sheaff M; Knuutila S
    Am J Pathol; 2000 Mar; 156(3):871-8. PubMed ID: 10702404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genetic alterations in upper urinary tract urothelial carcinoma in end-stage renal disease patients.
    Wu CF; Pang ST; Shee JJ; Chang PL; Chuang CK; Chen CS; Liao SK; Weng WH
    Genes Chromosomes Cancer; 2010 Oct; 49(10):928-34. PubMed ID: 20629096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization.
    Muscheck M; Abol-Enein H; Chew K; Moore D; Bhargava V; Ghoneim MA; Carroll PR; Waldman FM
    Carcinogenesis; 2000 Sep; 21(9):1721-6. PubMed ID: 10964104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder.
    Necchi A; Madison R; Raggi D; Jacob JM; Bratslavsky G; Shapiro O; Elvin JA; Vergilio JA; Killian JK; Ngo N; Ramkissoon S; Severson E; Hemmerich AC; Huang R; Ali SM; Chung JH; Reddy P; Miller VA; Schrock AB; Gay LM; Alexander BM; Grivas P; Ross JS
    Eur Urol; 2020 Apr; 77(4):548-556. PubMed ID: 31959546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear Cell Carcinoma of Salivary Glands Is Frequently p16 Positive: A Pitfall in the Interpretation of Oropharyngeal Biopsies.
    Bishop JA; Rooper LM; Chiosea SI; Westra WH
    Am J Surg Pathol; 2018 Mar; 42(3):367-371. PubMed ID: 29076874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?
    Vauhkonen H; Böhling T; Eissa S; Shoman S; Knuutila S
    Cancer Genet Cytogenet; 2007 Sep; 177(2):153-7. PubMed ID: 17854674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.
    Lindgren D; Sjödahl G; Lauss M; Staaf J; Chebil G; Lövgren K; Gudjonsson S; Liedberg F; Patschan O; Månsson W; Fernö M; Höglund M
    PLoS One; 2012; 7(6):e38863. PubMed ID: 22685613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
    Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
    Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Companied P16 genetic and protein status together providing useful information on the clinical outcome of urinary bladder cancer.
    Pu X; Zhu L; Fu Y; Fan Z; Zheng J; Zhang B; Yang J; Guan W; Wu H; Ye Q; Huang Q
    Medicine (Baltimore); 2018 Apr; 97(15):e0353. PubMed ID: 29642177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
    Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
    J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of genetic rearrangements in esophageal squamous carcinoma cell lines by a combination of M-FISH and array-CGH: further confirmation of some split genomic regions in primary tumors.
    Hao JJ; Shi ZZ; Zhao ZX; Zhang Y; Gong T; Li CX; Zhan T; Cai Y; Dong JT; Fu SB; Zhan QM; Wang MR
    BMC Cancer; 2012 Aug; 12():367. PubMed ID: 22920630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.
    Luk C; Tsao MS; Bayani J; Shepherd F; Squire JA
    Cancer Genet Cytogenet; 2001 Mar; 125(2):87-99. PubMed ID: 11369051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
    Asali MG; Kaneti J; Manor E
    Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.
    Lockwood WW; Chari R; Coe BP; Thu KL; Garnis C; Malloff CA; Campbell J; Williams AC; Hwang D; Zhu CQ; Buys TP; Yee J; English JC; Macaulay C; Tsao MS; Gazdar AF; Minna JD; Lam S; Lam WL
    PLoS Med; 2010 Jul; 7(7):e1000315. PubMed ID: 20668658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization.
    Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H
    Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
    Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
    Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic and Survival After Cystectomy Outcomes in Squamous Cell Carcinoma of the Bladder.
    Agrawal P; Rostom M; Alam R; Florissi I; Biles M; Rodriguez K; Hahn NM; Johnson BA; Matoso A; Smith A; Bivalacqua TJ; Kates M; Hoffman-Censits J; Patel SH
    Clin Genitourin Cancer; 2023 Dec; 21(6):631-638.e1. PubMed ID: 37336703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
    Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
    Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma.
    Tripathi N; Jo Y; Tripathi A; Sayegh N; Li H; Nussenzveig R; Haaland B; Thomas VM; Gupta S; Maughan BL; Swami U; Pal SK; Grivas P; Agarwal N; Sirohi D
    Urol Oncol; 2022 Nov; 40(11):493.e1-493.e7. PubMed ID: 35918248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.